Other
National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia
Total Trials
6
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed trials have results
Key Signals
2 recruiting
Enrollment Performance
Analytics
Phase 2
3(60.0%)
N/A
2(40.0%)
5Total
Phase 2(3)
N/A(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT04923958Not ApplicableRecruiting
Rapid Research in Diagnostics Development for TB Network
Role: collaborator
NCT07135622Not ApplicableCompleted
Xpert MTB/RIF Ultra Trial
Role: collaborator
NCT02715271Completed
Study of TB Lesions Obtained in Therapeutical Surgery
Role: collaborator
NCT04575519Phase 2Recruiting
Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis
Role: collaborator
NCT02781909Phase 2Completed
Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis
Role: collaborator
NCT02897180Phase 2Unknown
Efficacy of Nyaditum Resae(R) Against Active TB in Georgia
Role: collaborator
All 6 trials loaded